Increasing bacterial resistance in pediatric acute conjunctivitis (1997-1998)

S L Block1, J Hedrick, R Tyler

  • 1Kentucky Pediatric Research, Inc., Bardstown, Kentucky 40004, USA. SLBlock@pol.net

Insights

Pediatric conjunctivitis is often caused by Haemophilus influenzae and Streptococcus pneumoniae. High resistance rates were observed, with 69% of H. influenzae producing beta-lactamase and 32% of S. pneumoniae showing penicillin non-susceptibility.

Area of Science:

  • Ophthalmology
  • Microbiology
  • Pediatrics

Background:

  • Pediatric conjunctivitis is a common condition.
  • Haemophilus influenzae and Streptococcus pneumoniae are primary causative pathogens.
  • Understanding antimicrobial resistance patterns is crucial for effective treatment.

Purpose of the Study:

  • To determine the current antimicrobial resistance levels of H. influenzae and S. pneumoniae in pediatric conjunctivitis.
  • To assess the prevalence of beta-lactamase production in H. influenzae.
  • To evaluate the penicillin susceptibility of S. pneumoniae isolates.

Main Methods:

  • Prospective culture of acute conjunctivitis cases in 250 pediatric patients (January 1997-March 1998).
  • Isolation and identification of bacterial pathogens.
  • Antimicrobial susceptibility testing, including beta-lactamase detection and penicillin susceptibility testing.

Main Results:

  • H. influenzae (42%) and S. pneumoniae (30%) were the most common pathogens.
  • 69% of H. influenzae strains produced beta-lactamase.
  • 32% of S. pneumoniae isolates were non-susceptible to penicillin (26% resistant, 6% intermediate).
  • H. influenzae was frequently associated with conjunctivitis-otitis syndrome (57% of cases).
  • Ciprofloxacin, ofloxacin, and tetracycline showed the highest in vitro activity.

Conclusions:

  • H. influenzae remains a primary pathogen in pediatric conjunctivitis, with high rates of beta-lactamase production.
  • A significant proportion of S. pneumoniae isolates exhibit penicillin non-susceptibility.
  • Antimicrobial resistance patterns necessitate careful selection of treatments for pediatric conjunctivitis.

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Microbiome of the Eye01:22

Microbiome of the Eye

The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...